{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:45:57Z","timestamp":1792896357027,"version":"4.5.0"},"reference-count":214,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11030-025-11198-3","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:28:43Z","timestamp":1745569723000},"page":"59-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Network pharmacology approach to unravel the neuroprotective potential of natural products: a narrative review"],"prefix":"10.1007","volume":"30","author":[{"given":"Pankaj","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheshkumar","family":"Borkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8490-0705","authenticated-orcid":false,"given":"Gaurav","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"11198_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"J Guo","year":"2022","unstructured":"Guo J, Huang X, Dou L et al (2022) Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther 7:391. https:\/\/doi.org\/10.1038\/s41392-022-01251-0","journal-title":"Signal Transduct Target Ther"},{"key":"11198_CR2","doi-asserted-by":"publisher","first-page":"R741","DOI":"10.1016\/j.cub.2012.07.024","volume":"22","author":"T Niccoli","year":"2012","unstructured":"Niccoli T, Partridge L (2012) Ageing as a risk factor for disease. Curr Biol 22:R741\u2013R752. https:\/\/doi.org\/10.1016\/j.cub.2012.07.024","journal-title":"Curr Biol"},{"key":"11198_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/geronj\/11.3.298","volume":"11","author":"D Harman","year":"1956","unstructured":"Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11:298\u2013300. https:\/\/doi.org\/10.1093\/geronj\/11.3.298","journal-title":"J Gerontol"},{"key":"11198_CR4","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.1071","author":"S Wang","year":"2024","unstructured":"Wang S, Jiang Y, Yang A et al (2024) The expanding burden of neurodegenerative diseases: an unmet medical and social need. Aging Dis. https:\/\/doi.org\/10.14336\/AD.2024.1071","journal-title":"Aging Dis"},{"key":"11198_CR5","doi-asserted-by":"publisher","first-page":"e735","DOI":"10.1016\/S2214-109X(23)00602-2","volume":"12","author":"AS Winkler","year":"2024","unstructured":"Winkler AS, Gupta S, Patel V et al (2024) Global brain health\u2014the time to act is now. Lancet Glob Health 12:e735\u2013e736. https:\/\/doi.org\/10.1016\/S2214-109X(23)00602-2","journal-title":"Lancet Glob Health"},{"key":"11198_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-323-95901-8.00008-0","volume-title":"Clinical neuroepidemiology of acute and chronic disorders","author":"J Moini","year":"2023","unstructured":"Moini J, Gutierrez A, Avgeropoulos N (2023) Prevalence and incidence in neuroepidemiology. In: Moini J, Gutierrez A, Avgeropoulos N (eds) Clinical neuroepidemiology of acute and chronic disorders. Elsevier, Amsterdam, pp 3\u20138"},{"key":"11198_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vhri.2023.09.008","volume":"40","author":"LX Tay","year":"2024","unstructured":"Tay LX, Ong SC, Tay LJ et al (2024) Economic burden of Alzheimer\u2019s disease: a systematic review. Value Health Reg Issues 40:1\u201312. https:\/\/doi.org\/10.1016\/j.vhri.2023.09.008","journal-title":"Value Health Reg Issues"},{"key":"11198_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/ibra.12181","volume":"10","author":"M Su","year":"2024","unstructured":"Su M, Wang T, Zou C et al (2024) Global, regional, and national burdens of Alzheimer\u2019s disease and other forms of dementia in the elderly population from 1999 to 2019: a trend analysis based on the Global Burden of Disease Study 2019. Ibrain 10:488\u2013499. https:\/\/doi.org\/10.1002\/ibra.12181","journal-title":"Ibrain"},{"key":"11198_CR9","doi-asserted-by":"publisher","first-page":"e1534","DOI":"10.1016\/S2214-109X(24)00264-X","volume":"12","author":"S Chen","year":"2024","unstructured":"Chen S, Cao Z, Nandi A et al (2024) The global macroeconomic burden of Alzheimer\u2019s disease and other dementias: estimates and projections for 152 countries or territories. Lancet Glob Health 12:e1534\u2013e1543. https:\/\/doi.org\/10.1016\/S2214-109X(24)00264-X","journal-title":"Lancet Glob Health"},{"key":"11198_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.14283\/jpad.2022.81","volume":"10","author":"A-Y Wang","year":"2023","unstructured":"Wang A-Y, Hu H-Y, Ou Y-N et al (2023) Socioeconomic status and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 39 prospective studies. J Prev Alzheimers Dis 10:83\u201394. https:\/\/doi.org\/10.14283\/jpad.2022.81","journal-title":"J Prev Alzheimers Dis"},{"key":"11198_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/21678421.2024.2384992","volume":"25","author":"A Shojaie","year":"2024","unstructured":"Shojaie A, Al Khleifat A, Garrahy S et al (2024) Investigating the impact of socioeconomic status on amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 25:702\u2013707. https:\/\/doi.org\/10.1080\/21678421.2024.2384992","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"11198_CR12","doi-asserted-by":"publisher","first-page":"106867","DOI":"10.1016\/j.psyneuen.2023.106867","volume":"160","author":"A Gireesh","year":"2024","unstructured":"Gireesh A, Sacker A, McMunn A, Cadar D (2024) Neuro-immune markers, socioeconomic inequalities, and neurodegenerative conditions. Psychoneuroendocrinology 160:106867. https:\/\/doi.org\/10.1016\/j.psyneuen.2023.106867","journal-title":"Psychoneuroendocrinology"},{"key":"11198_CR13","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.1016\/S2666-7568(23)00233-7","volume":"4","author":"T Filippini","year":"2023","unstructured":"Filippini T, Vinceti M (2023) Social disparities and unhealthy lifestyles increase risk of dementia, particularly at a young age. Lancet Healthy Longev 4:e660\u2013e661. https:\/\/doi.org\/10.1016\/S2666-7568(23)00233-7","journal-title":"Lancet Healthy Longev"},{"key":"11198_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109624","volume":"121","author":"R Li","year":"2020","unstructured":"Li R, Li Q, Ji Q (2020) Molecular targeted study in tumors: from western medicine to active ingredients of traditional Chinese medicine. Biomed Pharmacother 121:109624. https:\/\/doi.org\/10.1016\/j.biopha.2019.109624","journal-title":"Biomed Pharmacother"},{"key":"11198_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116306","volume":"309","author":"L Zhao","year":"2023","unstructured":"Zhao L, Zhang H, Li N et al (2023) Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol 309:116306. https:\/\/doi.org\/10.1016\/j.jep.2023.116306","journal-title":"J Ethnopharmacol"},{"key":"11198_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1419110","author":"SM Stefan","year":"2024","unstructured":"Stefan SM, Rafehi M (2024) Medicinal polypharmacology\u2014a scientific glossary of terminology and concepts. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1419110","journal-title":"Front Pharmacol"},{"key":"11198_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-981-16-9232-1_2","volume-title":"Biomedical translational research","author":"TR Sahrawat","year":"2022","unstructured":"Sahrawat TR, Sobti RC (2022) Polypharmacology: new paradigms in drug development. Biomedical translational research. Springer, Singapore, pp 17\u201326"},{"key":"11198_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad120","author":"F Noor","year":"2023","unstructured":"Noor F, Asif M, Ashfaq UA et al (2023) Machine learning for synergistic network pharmacology: a comprehensive overview. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbad120","journal-title":"Brief Bioinform"},{"key":"11198_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/B978-0-443-16102-5.00004-3","volume-title":"Computational phytochemistry","author":"AA Fatokun","year":"2024","unstructured":"Fatokun AA, Nahar L, Sarker SD (2024) Network pharmacology in phytochemical research. Computational phytochemistry. Elsevier, Amsterdam, pp 465\u2013493"},{"key":"11198_CR20","doi-asserted-by":"publisher","first-page":"15340","DOI":"10.3390\/ijms242015340","volume":"24","author":"SE Davis","year":"2023","unstructured":"Davis SE, Cirincione AB, Jimenez-Torres AC, Zhu J (2023) The impact of neurotransmitters on the neurobiology of neurodegenerative diseases. Int J Mol Sci 24:15340. https:\/\/doi.org\/10.3390\/ijms242015340","journal-title":"Int J Mol Sci"},{"key":"11198_CR21","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/B978-0-12-821618-7.00266-2","volume-title":"Encyclopedia of cell biology","author":"O Sirozh","year":"2023","unstructured":"Sirozh O, Saez-Mas A, Lafarga V, Fernandez-Capetillo O (2023) Basic concepts and emergent disease mechanisms of amyotrophic lateral sclerosis. Encyclopedia of cell biology. Elsevier, Amsterdam, pp 644\u2013665"},{"key":"11198_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-981-13-0944-1_5","volume-title":"Pathology, prevention and therapeutics of neurodegenerative disease","author":"ZM Ign\u00e1cio","year":"2019","unstructured":"Ign\u00e1cio ZM, Quevedo J, R\u00e9us GZ (2019) Pathophysiological mechanisms of Huntington\u2019s disease. Pathology, prevention and therapeutics of neurodegenerative disease. Springer, Singapore, pp 49\u201360"},{"key":"11198_CR23","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/biomedicines10061432","volume":"10","author":"A Jurcau","year":"2022","unstructured":"Jurcau A (2022) Molecular pathophysiological mechanisms in Huntington\u2019s disease. Biomedicines 10:1432. https:\/\/doi.org\/10.3390\/biomedicines10061432","journal-title":"Biomedicines"},{"key":"11198_CR24","doi-asserted-by":"publisher","first-page":"22a","DOI":"10.1016\/j.bpj.2021.11.2604","volume":"121","author":"P Rodriguez-Aliaga","year":"2022","unstructured":"Rodriguez-Aliaga P, Sosa RP, Bustamante C, Frydman J (2022) Dissecting the structural basis of Huntingtin pathogenesis: one molecule at the time. Biophys J 121:22a. https:\/\/doi.org\/10.1016\/j.bpj.2021.11.2604","journal-title":"Biophys J"},{"key":"11198_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s001090050059","volume":"74","author":"C Brahe","year":"1996","unstructured":"Brahe C, Bertini E (1996) Spinal muscular atrophies: recent insights and impact on molecular diagnosis. J Mol Med 74:555\u2013562. https:\/\/doi.org\/10.1007\/s001090050059","journal-title":"J Mol Med"},{"key":"11198_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00019052-199904000-00002","volume":"12","author":"NH Gendron","year":"1999","unstructured":"Gendron NH, MacKenzie AE (1999) Spinal muscular atrophy: molecular pathophysiology. Curr Opin Neurol 12:137\u2013142. https:\/\/doi.org\/10.1097\/00019052-199904000-00002","journal-title":"Curr Opin Neurol"},{"key":"11198_CR27","first-page":"159","volume-title":"Role of network pharmacology in prediction of mechanism of neuroprotective compounds","author":"Saima","year":"2024","unstructured":"Saima, Latha S, Sharma R, Kumar A (2024) Role of network pharmacology in prediction of mechanism of neuroprotective compounds. Springer, New York, pp 159\u2013179"},{"key":"11198_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.9734\/ajob\/2023\/v19i2364","volume":"19","author":"S Bonthu","year":"2023","unstructured":"Bonthu S, Pulichintha S, Ganga Raju M, Suvarchala Reddy V NVL (2023) Network pharmacology approach for herbal drugs intended for the therapy of diseases: a comprehensive review. Asian J Biol 19:63\u201372. https:\/\/doi.org\/10.9734\/ajob\/2023\/v19i2364","journal-title":"Asian J Biol"},{"key":"11198_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.47191\/ijmscrs\/v2-i12-40","volume":"2","author":"N Bhatia","year":"2022","unstructured":"Bhatia N, Mokashi A, Nathore N, Nathore A (2022) Network pharmacology: an emphasis on traditional Chinese medicines and its adaptability for ayurveda medicines in India. Int J Med Sci Clin Res Stud 2:1. https:\/\/doi.org\/10.47191\/ijmscrs\/v2-i12-40","journal-title":"Int J Med Sci Clin Res Stud"},{"key":"11198_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.19540\/j.cnki.cjcmm.20210914.702","volume":"47","author":"Z-Y Wang","year":"2022","unstructured":"Wang Z-Y, Wang X, Zhang D-Y et al (2022) Traditional Chinese medicine network pharmacology: development in new era under guidance of network pharmacology evaluation method guidance. Zhongguo Zhong Yao Za Zhi 47:7\u201317. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20210914.702","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"11198_CR31","doi-asserted-by":"publisher","first-page":"W32","DOI":"10.1093\/nar\/gku293","volume":"42","author":"D Gfeller","year":"2014","unstructured":"Gfeller D, Grosdidier A, Wirth M et al (2014) SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res 42:W32\u2013W38. https:\/\/doi.org\/10.1093\/nar\/gku293","journal-title":"Nucleic Acids Res"},{"key":"11198_CR32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea G, Mlecnik B, Hackl H et al (2009) ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25:1091\u20131093. https:\/\/doi.org\/10.1093\/bioinformatics\/btp101","journal-title":"Bioinformatics"},{"key":"11198_CR33","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC et al (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46:D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","journal-title":"Nucleic Acids Res"},{"key":"11198_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.5","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I et al (2016) The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. https:\/\/doi.org\/10.1002\/cpbi.5","journal-title":"Curr Protoc Bioinformatics"},{"key":"11198_CR35","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","volume":"44","author":"D Szklarczyk","year":"2016","unstructured":"Szklarczyk D, Santos A, von Mering C et al (2016) STITCH 5: augmenting protein\u2013chemical interaction networks with tissue and affinity data. Nucleic Acids Res 44:D380\u2013D384. https:\/\/doi.org\/10.1093\/nar\/gkv1277","journal-title":"Nucleic Acids Res"},{"key":"11198_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211","journal-title":"Nat Protoc"},{"key":"11198_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","volume":"25","author":"MJ Keiser","year":"2007","unstructured":"Keiser MJ, Roth BL, Armbruster BN et al (2007) Relating protein pharmacology by ligand chemistry. Nat Biotechnol 25:197\u2013206. https:\/\/doi.org\/10.1038\/nbt1284","journal-title":"Nat Biotechnol"},{"key":"11198_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002607","volume":"22","author":"AM Eteleeb","year":"2024","unstructured":"Eteleeb AM, Novotny BC, Tarraga CS et al (2024) Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer\u2019s disease. PLoS Biol 22:e3002607. https:\/\/doi.org\/10.1371\/journal.pbio.3002607","journal-title":"PLoS Biol"},{"key":"11198_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/14789450.2024.2315193","volume":"21","author":"P G\u0105tarek","year":"2024","unstructured":"G\u0105tarek P, Ka\u0142u\u017cna-Czapli\u0144ska J (2024) Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson\u2019s disease. Expert Rev Proteomics 21:13\u201325. https:\/\/doi.org\/10.1080\/14789450.2024.2315193","journal-title":"Expert Rev Proteomics"},{"key":"11198_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae265","author":"JH Yoon","year":"2024","unstructured":"Yoon JH, Lee H, Kwon D et al (2024) Integrative approach of omics and imaging data to discover new insights for understanding brain diseases. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcae265","journal-title":"Brain Commun"},{"key":"11198_CR41","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/biology13110848","volume":"13","author":"PHG Sanches","year":"2024","unstructured":"Sanches PHG, de Melo NC, Porcari AM, de Carvalho LM (2024) Integrating molecular perspectives: strategies for comprehensive multi-omics integrative data analysis and machine learning applications in transcriptomics, proteomics, and metabolomics. Biology (Basel) 13:848. https:\/\/doi.org\/10.3390\/biology13110848","journal-title":"Biology (Basel)"},{"key":"11198_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2024.108254","volume":"113","author":"EH Abdelaziz","year":"2024","unstructured":"Abdelaziz EH, Ismail R, Mabrouk MS, Amin E (2024) Multi-omics data integration and analysis pipeline for precision medicine: Systematic review. Comput Biol Chem 113:108254. https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108254","journal-title":"Comput Biol Chem"},{"key":"11198_CR43","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/psp4.13047","volume":"12","author":"B Ribba","year":"2023","unstructured":"Ribba B (2023) Quantitative systems pharmacology in the age of artificial intelligence. CPT Pharmacomet Syst Pharmacol 12:1823\u20131826. https:\/\/doi.org\/10.1002\/psp4.13047","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"11198_CR44","doi-asserted-by":"publisher","first-page":"824","DOI":"10.22214\/ijraset.2023.50032","volume":"11","author":"PG Vyawhare","year":"2023","unstructured":"Vyawhare PG, Ahire GM, Yadav NM, Tasgaonkar DrRR (2023) Neurodegenerative disorder. Int J Res Appl Sci Eng Technol 11:824\u2013828. https:\/\/doi.org\/10.22214\/ijraset.2023.50032","journal-title":"Int J Res Appl Sci Eng Technol"},{"key":"11198_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-981-33-6009-9_11","volume-title":"Introduction to basics of pharmacology and toxicology","author":"NJ Shah","year":"2021","unstructured":"Shah NJ (2021) Pharmacotherapy of neurodegenerative disorders. Introduction to basics of pharmacology and toxicology. Springer, Singapore, pp 205\u2013212"},{"key":"11198_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2021.100022","volume":"2","author":"DK Khatri","year":"2021","unstructured":"Khatri DK, Kadbhane A, Patel M et al (2021) Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders. Curr Res Pharmacol Drug Discov 2:100022. https:\/\/doi.org\/10.1016\/j.crphar.2021.100022","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"11198_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-3-319-60408-4_4","volume-title":"Emerging trends in chemical sciences","author":"G Nagesh Babu","year":"2018","unstructured":"Nagesh Babu G, Gupta M (2018) Therapeutics in neurodegenerative disorders: emerging compounds of interest. Emerging trends in chemical sciences. Springer, Cham, pp 37\u201356"},{"key":"11198_CR48","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.3390\/ijms25063245","volume":"25","author":"T Ganz","year":"2024","unstructured":"Ganz T, Ben-Hur T (2024) The \u201chit and run\u201d hypothesis for Alzheimer\u2019s disease pathogenesis. Int J Mol Sci 25:3245. https:\/\/doi.org\/10.3390\/ijms25063245","journal-title":"Int J Mol Sci"},{"key":"11198_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04457-1","author":"J Miao","year":"2024","unstructured":"Miao J, Zhang Y, Su C et al (2024) Insulin-like growth factor signaling in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04457-1","journal-title":"Mol Neurobiol"},{"key":"11198_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101273","volume":"101","author":"BP Gaire","year":"2024","unstructured":"Gaire BP, Koronyo Y, Fuchs D-T et al (2024) Alzheimer\u2019s disease pathophysiology in the Retina. Prog Retin Eye Res 101:101273. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101273","journal-title":"Prog Retin Eye Res"},{"key":"11198_CR51","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.3390\/molecules29215131","volume":"29","author":"AM Thawabteh","year":"2024","unstructured":"Thawabteh AM, Ghanem AW, AbuMadi S et al (2024) Recent advances in therapeutics for the treatment of Alzheimer\u2019s disease. Molecules 29:5131. https:\/\/doi.org\/10.3390\/molecules29215131","journal-title":"Molecules"},{"key":"11198_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102270","volume":"96","author":"VN Almeida","year":"2024","unstructured":"Almeida VN (2024) Somatostatin and the pathophysiology of Alzheimer\u2019s disease. Ageing Res Rev 96:102270. https:\/\/doi.org\/10.1016\/j.arr.2024.102270","journal-title":"Ageing Res Rev"},{"key":"11198_CR53","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1002\/alz.12970","volume":"19","author":"M \u010carna","year":"2023","unstructured":"\u010carna M, Onyango IG, Katina S et al (2023) Pathogenesis of Alzheimer\u2019s disease: involvement of the choroid plexus. Alzheimer\u2019s Dementia 19:3537\u20133554. https:\/\/doi.org\/10.1002\/alz.12970","journal-title":"Alzheimer\u2019s Dementia"},{"key":"11198_CR54","doi-asserted-by":"publisher","first-page":"12498","DOI":"10.3390\/ijms241512498","volume":"24","author":"EO Olufunmilayo","year":"2023","unstructured":"Olufunmilayo EO, Holsinger RMD (2023) Roles of non-coding RNA in Alzheimer\u2019s disease pathophysiology. Int J Mol Sci 24:12498. https:\/\/doi.org\/10.3390\/ijms241512498","journal-title":"Int J Mol Sci"},{"key":"11198_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.932572","author":"M-K St-Pierre","year":"2022","unstructured":"St-Pierre M-K, VanderZwaag J, Loewen S, Tremblay M-\u00c8 (2022) All roads lead to heterogeneity: the complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer\u2019s disease. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2022.932572","journal-title":"Front Cell Neurosci"},{"key":"11198_CR56","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s12035-024-04315-0","volume":"62","author":"D Radosinska","year":"2025","unstructured":"Radosinska D, Radosinska J (2025) The link between matrix metalloproteinases and Alzheimer\u2019s disease pathophysiology. Mol Neurobiol 62:885\u2013899. https:\/\/doi.org\/10.1007\/s12035-024-04315-0","journal-title":"Mol Neurobiol"},{"key":"11198_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11011-021-00800-w","volume":"37","author":"N Pathak","year":"2022","unstructured":"Pathak N, Vimal SK, Tandon I et al (2022) Neurodegenerative disorders of Alzheimer, Parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: an early diagnostic approach for precision treatment. Metab Brain Dis 37:67\u2013104. https:\/\/doi.org\/10.1007\/s11011-021-00800-w","journal-title":"Metab Brain Dis"},{"key":"11198_CR58","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1038\/s41380-023-02251-4","volume":"28","author":"E Tresse","year":"2023","unstructured":"Tresse E, Marturia-Navarro J, Sew WQG et al (2023) Mitochondrial DNA damage triggers spread of Parkinson\u2019s disease-like pathology. Mol Psychiatry 28:4902\u20134914. https:\/\/doi.org\/10.1038\/s41380-023-02251-4","journal-title":"Mol Psychiatry"},{"key":"11198_CR59","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.3390\/ijms252111406","volume":"25","author":"SG Kim","year":"2024","unstructured":"Kim SG, Hwang JS, George NP et al (2024) Integrative metabolome and proteome analysis of cerebrospinal fluid in Parkinson\u2019s disease. Int J Mol Sci 25:11406. https:\/\/doi.org\/10.3390\/ijms252111406","journal-title":"Int J Mol Sci"},{"key":"11198_CR60","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/ijms23020678","volume":"23","author":"T Behl","year":"2022","unstructured":"Behl T, Madaan P, Sehgal A et al (2022) mechanistic insights expatiating the redox-active-metal-mediated neuronal degeneration in Parkinson\u2019s disease. Int J Mol Sci 23:678. https:\/\/doi.org\/10.3390\/ijms23020678","journal-title":"Int J Mol Sci"},{"key":"11198_CR61","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 403:293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2","journal-title":"Lancet"},{"key":"11198_CR62","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.3390\/ijms25084337","volume":"25","author":"A Repici","year":"2024","unstructured":"Repici A, Capra AP, Hasan A et al (2024) Novel findings on CCR1 receptor in CNS disorders: a pathogenic marker useful in controlling neuroimmune and neuroinflammatory mechanisms in Parkinson\u2019s disease. Int J Mol Sci 25:4337. https:\/\/doi.org\/10.3390\/ijms25084337","journal-title":"Int J Mol Sci"},{"key":"11198_CR63","doi-asserted-by":"publisher","first-page":"S399","DOI":"10.3233\/JAD-220682","volume":"94","author":"P Naren","year":"2023","unstructured":"Naren P, Cholkar A, Kamble S et al (2023) Pathological and therapeutic advances in Parkinson\u2019s disease: mitochondria in the interplay. J Alzheimer\u2019s Dis 94:S399\u2013S428. https:\/\/doi.org\/10.3233\/JAD-220682","journal-title":"J Alzheimer\u2019s Dis"},{"key":"11198_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405309","author":"H Yan","year":"2024","unstructured":"Yan H, Coughlin C, Smolin L, Wang J (2024) Unraveling the complexity of Parkinson\u2019s disease: insights into pathogenesis and precision interventions. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202405309","journal-title":"Adv Sci"},{"key":"11198_CR65","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/ph15070811","volume":"15","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yao L, Zheng Z et al (2022) The role of non-coding RNAs in the pathogenesis of Parkinson\u2019s disease: recent advancement. Pharmaceuticals 15:811. https:\/\/doi.org\/10.3390\/ph15070811","journal-title":"Pharmaceuticals"},{"key":"11198_CR66","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/mds.29374","volume":"38","author":"T Kamath","year":"2023","unstructured":"Kamath T, Macosko EZ (2023) Insights into neurodegeneration in Parkinson\u2019s disease from single-cell and spatial genomics. Mov Disord 38:518\u2013525. https:\/\/doi.org\/10.1002\/mds.29374","journal-title":"Mov Disord"},{"key":"11198_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2024.102841","volume":"85","author":"SM Brooker","year":"2024","unstructured":"Brooker SM, Naylor GE, Krainc D (2024) Cell biology of Parkinson\u2019s disease: mechanisms of synaptic, lysosomal, and mitochondrial dysfunction. Curr Opin Neurobiol 85:102841. https:\/\/doi.org\/10.1016\/j.conb.2024.102841","journal-title":"Curr Opin Neurobiol"},{"key":"11198_CR68","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/jnen\/nlac110","volume":"82","author":"K Takahashi","year":"2023","unstructured":"Takahashi K (2023) Microglial heterogeneity in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 82:140\u2013149. https:\/\/doi.org\/10.1093\/jnen\/nlac110","journal-title":"J Neuropathol Exp Neurol"},{"key":"11198_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.851563","author":"A Mirian","year":"2022","unstructured":"Mirian A, Moszczynski A, Soleimani S et al (2022) Breached barriers: a scoping review of blood\u2013central nervous system barrier pathology in amyotrophic lateral sclerosis. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2022.851563","journal-title":"Front Cell Neurosci"},{"key":"11198_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2023.102449","volume":"226","author":"LA Reale","year":"2023","unstructured":"Reale LA, Dyer MS, Perry SE et al (2023) Pathologically mislocalised TDP-43 in upper motor neurons causes a die-forward spread of ALS-like pathogenic changes throughout the mouse corticomotor system. Prog Neurobiol 226:102449. https:\/\/doi.org\/10.1016\/j.pneurobio.2023.102449","journal-title":"Prog Neurobiol"},{"key":"11198_CR71","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00401-023-02611-y","volume":"146","author":"A Aly","year":"2023","unstructured":"Aly A, Laszlo ZI, Rajkumar S et al (2023) Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS. Acta Neuropathol 146:451\u2013475. https:\/\/doi.org\/10.1007\/s00401-023-02611-y","journal-title":"Acta Neuropathol"},{"key":"11198_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2024.102587","volume":"235","author":"V La Cognata","year":"2024","unstructured":"La Cognata V, Morello G, Guarnaccia M, Cavallaro S (2024) The multifaceted role of the CXC chemokines and receptors signaling axes in ALS pathophysiology. Prog Neurobiol 235:102587. https:\/\/doi.org\/10.1016\/j.pneurobio.2024.102587","journal-title":"Prog Neurobiol"},{"key":"11198_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678421.2024.2405130","volume":"26","author":"J Kleinerova","year":"2025","unstructured":"Kleinerova J, Garcia-Gallardo A, Tacheva A, Bede P (2025) Subcortical grey matter involvement in ALS and PLS\u2014vulnerable hubs of cortico-cortical and cortico-basal circuits: extrapyramidal, cognitive, bulbar and respiratory correlates. Amyotroph Lateral Scler Frontotemporal Degener 26:1\u20134. https:\/\/doi.org\/10.1080\/21678421.2024.2405130","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"11198_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105156","volume":"147","author":"A Shatunov","year":"2021","unstructured":"Shatunov A, Al-Chalabi A (2021) The genetic architecture of ALS. Neurobiol Dis 147:105156. https:\/\/doi.org\/10.1016\/j.nbd.2020.105156","journal-title":"Neurobiol Dis"},{"key":"11198_CR75","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006317","author":"C Crockford","year":"2018","unstructured":"Crockford C, Newton J, Lonergan K et al (2018) ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000006317","journal-title":"Neurology"},{"key":"11198_CR76","doi-asserted-by":"publisher","first-page":"13021","DOI":"10.3390\/ijms241613021","volume":"24","author":"A Jiang","year":"2023","unstructured":"Jiang A, Handley RR, Lehnert K, Snell RG (2023) From pathogenesis to therapeutics: a review of 150 years of Huntington\u2019s disease research. Int J Mol Sci 24:13021. https:\/\/doi.org\/10.3390\/ijms241613021","journal-title":"Int J Mol Sci"},{"key":"11198_CR77","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/hmg\/ddae087","volume":"33","author":"A Jiang","year":"2024","unstructured":"Jiang A, You L, Handley RR et al (2024) Single nuclei RNA-seq reveals a medium spiny neuron glutamate excitotoxicity signature prior to the onset of neuronal death in an ovine Huntington\u2019s disease model. Hum Mol Genet 33:1524\u20131539. https:\/\/doi.org\/10.1093\/hmg\/ddae087","journal-title":"Hum Mol Genet"},{"key":"11198_CR78","doi-asserted-by":"publisher","first-page":"11787","DOI":"10.3390\/ijms252111787","volume":"25","author":"X Li","year":"2024","unstructured":"Li X, Tong H, Xu S et al (2024) Neuroinflammatory proteins in Huntington\u2019s disease: insights into mechanisms, diagnosis, and therapeutic implications. Int J Mol Sci 25:11787. https:\/\/doi.org\/10.3390\/ijms252111787","journal-title":"Int J Mol Sci"},{"key":"11198_CR79","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/JHD-240028","volume":"13","author":"Y Alshehabi","year":"2024","unstructured":"Alshehabi Y, Martin DDO (2024) Protective proteolysis in Huntington\u2019s disease: unraveling the role of post-translational myristoylation of huntingtin in autophagy. J Huntingtons Dis 13:267\u2013277. https:\/\/doi.org\/10.3233\/JHD-240028","journal-title":"J Huntingtons Dis"},{"key":"11198_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.mocell.2024.100046","volume":"47","author":"YM Oh","year":"2024","unstructured":"Oh YM, Lee SW (2024) Patient-derived neuron model: capturing age-dependent adult-onset degenerative pathology in Huntington\u2019s disease. Mol Cells 47:100046. https:\/\/doi.org\/10.1016\/j.mocell.2024.100046","journal-title":"Mol Cells"},{"key":"11198_CR81","doi-asserted-by":"publisher","first-page":"11493","DOI":"10.3390\/ijms252111493","volume":"25","author":"AE Zubkova","year":"2024","unstructured":"Zubkova AE, Yudkin DV (2024) Regulation of HTT mRNA biogenesis: the norm and pathology. Int J Mol Sci 25:11493. https:\/\/doi.org\/10.3390\/ijms252111493","journal-title":"Int J Mol Sci"},{"key":"11198_CR82","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddae087","author":"A Jiang","year":"2024","unstructured":"Jiang A, You L, Handley RR et al (2024) Single nuclei RNA-seq reveals a medium spiny neuron glutamate excitotoxicity signature prior to the onset of neuronal death in an ovine Huntington\u2019s disease model. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddae087","journal-title":"Hum Mol Genet"},{"key":"11198_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad214","author":"C-F Liu","year":"2023","unstructured":"Liu C-F, Younes L, Tong XJ et al (2023) Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington\u2019s disease. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcad214","journal-title":"Brain Commun"},{"key":"11198_CR84","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40478-022-01364-1","volume":"10","author":"RA Hickman","year":"2022","unstructured":"Hickman RA, Faust PL, Marder K et al (2022) The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade. Acta Neuropathol Commun 10:55. https:\/\/doi.org\/10.1186\/s40478-022-01364-1","journal-title":"Acta Neuropathol Commun"},{"key":"11198_CR85","doi-asserted-by":"publisher","DOI":"10.1177\/11779322231210098","author":"TM Meem","year":"2023","unstructured":"Meem TM, Khan U, Mredul MBR et al (2023) A comprehensive bioinformatics approach to identify molecular signatures and key pathways for the Huntington disease. Bioinform Biol Insights. https:\/\/doi.org\/10.1177\/11779322231210098","journal-title":"Bioinform Biol Insights"},{"key":"11198_CR86","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-2001-15264","volume":"21","author":"K Talbot","year":"2001","unstructured":"Talbot K, Davies KE (2001) Spinal muscular atrophy. Semin Neurol 21:189\u2013198. https:\/\/doi.org\/10.1055\/s-2001-15264","journal-title":"Semin Neurol"},{"key":"11198_CR87","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-90-481-2813-6_16","volume":"652","author":"J Vitte","year":"2009","unstructured":"Vitte J, Attali R, Warwar N et al (2009) Spinal muscular atrophy. Adv Exp Med Biol 652:237\u2013246","journal-title":"Adv Exp Med Biol"},{"key":"11198_CR88","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.25596","volume":"86","author":"K Maeda","year":"2019","unstructured":"Maeda K, Chong PF, Yamashita F et al (2019) Global central nervous system atrophy in spinal muscular atrophy type 0. Ann Neurol 86:801\u2013802. https:\/\/doi.org\/10.1002\/ana.25596","journal-title":"Ann Neurol"},{"key":"11198_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nan.13013","volume":"50","author":"H Allardyce","year":"2024","unstructured":"Allardyce H, Lawrence BD, Crawford TO et al (2024) A reassessment of spinal cord pathology in severe infantile spinal muscular atrophy. Neuropathol Appl Neurobiol 50:1. https:\/\/doi.org\/10.1111\/nan.13013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"11198_CR90","doi-asserted-by":"publisher","first-page":"12415","DOI":"10.3390\/ijms252212415","volume":"25","author":"MT Berciano","year":"2024","unstructured":"Berciano MT, Gatius A, Puente-Bedia A et al (2024) SMN deficiency induces an early non-atrophic myopathy with alterations in the contractile and excitatory coupling machinery of skeletal myofibers in the SMN\u22067 mouse model of spinal muscular atrophy. Int J Mol Sci 25:12415. https:\/\/doi.org\/10.3390\/ijms252212415","journal-title":"Int J Mol Sci"},{"key":"11198_CR91","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.92731.3","author":"S-H Hann","year":"2024","unstructured":"Hann S-H, Kim S-Y, Kim YL et al (2024) Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy. Elife. https:\/\/doi.org\/10.7554\/eLife.92731.3","journal-title":"Elife"},{"key":"11198_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1307636","author":"S Rashid","year":"2024","unstructured":"Rashid S, Dimitriadi M (2024) Autophagy in spinal muscular atrophy: from pathogenic mechanisms to therapeutic approaches. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2023.1307636","journal-title":"Front Cell Neurosci"},{"key":"11198_CR93","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1042\/BST20231116","volume":"52","author":"G Sharma","year":"2024","unstructured":"Sharma G, Paganin M, Lauria F et al (2024) The SMN-ribosome interplay: a new opportunity for spinal muscular atrophy therapies. Biochem Soc Trans 52:465\u2013479. https:\/\/doi.org\/10.1042\/BST20231116","journal-title":"Biochem Soc Trans"},{"key":"11198_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.171878","volume":"8","author":"NN Jha","year":"2023","unstructured":"Jha NN, Kim J-K, Her Y-R, Monani UR (2023) Muscle: to the neuromuscular disease phenotype in spinal muscular atrophy. JCI Insight 8:1. https:\/\/doi.org\/10.1172\/jci.insight.171878","journal-title":"JCI Insight"},{"key":"11198_CR95","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.pcl.2023.06.002","volume":"70","author":"A Fay","year":"2023","unstructured":"Fay A (2023) Spinal muscular atrophy. Pediatr Clin N Am 70:963\u2013977. https:\/\/doi.org\/10.1016\/j.pcl.2023.06.002","journal-title":"Pediatr Clin N Am"},{"key":"11198_CR96","doi-asserted-by":"publisher","first-page":"14873","DOI":"10.3390\/ijms241914873","volume":"24","author":"I Angilletta","year":"2023","unstructured":"Angilletta I, Ferrante R, Giansante R et al (2023) Spinal muscular atrophy: an evolving scenario through new perspectives in diagnosis and advances in therapies. Int J Mol Sci 24:14873. https:\/\/doi.org\/10.3390\/ijms241914873","journal-title":"Int J Mol Sci"},{"key":"11198_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6532827","volume":"2020","author":"MT Gabr","year":"2020","unstructured":"Gabr MT, Yahiaoui S (2020) Multitarget therapeutics for neurodegenerative diseases. Biomed Res Int 2020:1\u20132. https:\/\/doi.org\/10.1155\/2020\/6532827","journal-title":"Biomed Res Int"},{"key":"11198_CR98","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2174\/1871527319666200717091513","volume":"19","author":"R Ghai","year":"2020","unstructured":"Ghai R, Nagarajan K, Arora M et al (2020) Current strategies and novel drug approaches for Alzheimer disease. CNS Neurol Disord Drug Targets 19:676\u2013690. https:\/\/doi.org\/10.2174\/1871527319666200717091513","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"11198_CR99","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/biomedicines10020371","volume":"10","author":"NA Gouda","year":"2022","unstructured":"Gouda NA, Elkamhawy A, Cho J (2022) Emerging therapeutic strategies for Parkinson\u2019s disease and future prospects: a 2021 update. Biomedicines 10:371. https:\/\/doi.org\/10.3390\/biomedicines10020371","journal-title":"Biomedicines"},{"key":"11198_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1109400","author":"J Zhu","year":"2023","unstructured":"Zhu J, Liang Q, He S et al (2023) Research trends and hotspots of neurodegenerative diseases employing network pharmacology: a bibliometric analysis. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1109400","journal-title":"Front Pharmacol"},{"key":"11198_CR101","doi-asserted-by":"publisher","first-page":"106","DOI":"10.13048\/jkm.23019","volume":"44","author":"B Kweon","year":"2023","unstructured":"Kweon B, Ryu S, Kim D-U et al (2023) Network pharmacology-based prediction of efficacy and mechanism of Chongmyunggongjin-dan acting on Alzheimer\u2019s disease. J Korean Med 44:106\u2013118. https:\/\/doi.org\/10.13048\/jkm.23019","journal-title":"J Korean Med"},{"key":"11198_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273583","volume":"17","author":"Y Luo","year":"2022","unstructured":"Luo Y, Shan L, Xu L et al (2022) A network pharmacology-based approach to explore the therapeutic potential of Sceletium tortuosum in the treatment of neurodegenerative disorders. PLoS ONE 17:e0273583. https:\/\/doi.org\/10.1371\/journal.pone.0273583","journal-title":"PLoS ONE"},{"key":"11198_CR103","doi-asserted-by":"publisher","first-page":"1254881","DOI":"10.3389\/fnins.2023.1254881","volume":"17","author":"Z Sun","year":"2023","unstructured":"Sun Z, Wu E, Wang Y (2023) Mechanism and pharmacodynamic material basis of neurodegenerative disease therapies. Front Neurosci 17:1254881","journal-title":"Front Neurosci"},{"key":"11198_CR104","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-981-99-6637-0_12","volume-title":"Computational methods in psychiatry","author":"K Bhattacharya","year":"2023","unstructured":"Bhattacharya K, Devanath B, Das D et al (2023) Recent developments in the application of computer-aided drug design in neurodegenerative disorders. Computational methods in psychiatry. Springer, Singapore, pp 227\u2013258"},{"key":"11198_CR105","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3288079\/v1","author":"SS Nazir","year":"2023","unstructured":"Nazir SS, Goel D, Vohora D (2023) A network-like pharmacology based approach to decipher the pharmacological mechanisms of salvia officinalis in neurodegenerative disorders. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-3288079\/v1","journal-title":"Res Square"},{"issue":"6","key":"11198_CR106","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.52711\/0974-360X.2024.00449","volume":"17","author":"Z Fernandes","year":"2024","unstructured":"Fernandes Z, Dattatreya KS, Kulkarni SD (2024) Integration of the computational tools to decode the mode of action of Citrus limon against Alzheimer\u2019s disease. Res J Pharm Technol 17(6):2863\u20132868. https:\/\/doi.org\/10.52711\/0974-360X.2024.00449","journal-title":"Res J Pharm Technol"},{"key":"11198_CR107","doi-asserted-by":"publisher","first-page":"127","DOI":"10.25303\/1906rjbt01270136","volume":"19","author":"AG Nambiyar","year":"2024","unstructured":"Nambiyar AG, Durairaj B (2024) Network pharmacology and molecular docking-based systemic approach to investigate the mechanism and molecular targets of phloridzin against Alzheimer\u2019s disease. Res J Biotechnol 19:127\u2013136. https:\/\/doi.org\/10.25303\/1906rjbt01270136","journal-title":"Res J Biotechnol"},{"key":"11198_CR108","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2024.2308756","author":"MA Alamri","year":"2024","unstructured":"Alamri MA, Tahir ul Qamar M, (2024) Network pharmacology and molecular dynamic simulation integrated strategy for the screening of active components and mechanisms of phytochemicals from Datura innoxia on Alzheimer and cognitive decline. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2024.2308756","journal-title":"J Biomol Struct Dyn"},{"key":"11198_CR109","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3474607\/v1","author":"D Uvarajan","year":"2023","unstructured":"Uvarajan D, Ravikumar M, Durairaj B (2023) Network analysis and molecular mapping for Alzheimer\u2019s disease to reveal the drug targets of arbutin. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-3474607\/v1","journal-title":"Res Square"},{"key":"11198_CR110","first-page":"433","volume-title":"Network pharmacology for drug repositioning in anti-Alzheimer\u2019s drug development","author":"R Dash","year":"2023","unstructured":"Dash R, Munni YA, Mitra S et al (2023) Network pharmacology for drug repositioning in anti-Alzheimer\u2019s drug development. Springer, New York, pp 433\u2013463"},{"key":"11198_CR111","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3390\/biom14101330","volume":"14","author":"C Vicidomini","year":"2024","unstructured":"Vicidomini C, Fontanella F, D\u2019Alessandro T, Roviello GN (2024) A survey on computational methods in drug discovery for neurodegenerative diseases. Biomolecules 14:1330. https:\/\/doi.org\/10.3390\/biom14101330","journal-title":"Biomolecules"},{"key":"11198_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253614","volume":"16","author":"Y Han","year":"2021","unstructured":"Han Y, Wang C, Klinger K et al (2021) An integrative network-based approach for drug target indication expansion. PLoS ONE 16:e0253614. https:\/\/doi.org\/10.1371\/journal.pone.0253614","journal-title":"PLoS ONE"},{"key":"11198_CR113","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s11064-021-03315-z","volume":"46","author":"J Wang","year":"2021","unstructured":"Wang J, Chen X, Bai W et al (2021) Study on mechanism of Ginkgo biloba L. leaves for the treatment of neurodegenerative diseases based on network pharmacology. Neurochem Res 46:1881\u20131894. https:\/\/doi.org\/10.1007\/s11064-021-03315-z","journal-title":"Neurochem Res"},{"key":"11198_CR114","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3892\/etm.2021.10687","volume":"22","author":"X Yang","year":"2021","unstructured":"Yang X, Guan Y, Yan B et al (2021) Evidence-based complementary and alternative medicine bioinformatics approach through network pharmacology and molecular docking to determine the molecular mechanisms of Erjing pill in Alzheimer\u2019s disease. Exp Ther Med 22:1252. https:\/\/doi.org\/10.3892\/etm.2021.10687","journal-title":"Exp Ther Med"},{"key":"11198_CR115","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.12955","author":"XG Liu","year":"2019","unstructured":"Liu XG, Lv MC, Huang MY et al (2019) A network pharmacology study on the triterpene saponins from Medicago sativa L. for the treatment of Neurodegenerative diseases. J Food Biochem. https:\/\/doi.org\/10.1111\/jfbc.12955","journal-title":"J Food Biochem"},{"key":"11198_CR116","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14068","author":"DQ Li","year":"2022","unstructured":"Li DQ, Jiang F, Zhang HS et al (2022) Network pharmacology-based approach to investigate the mechanisms of Zingiber officinale Roscoe in the treatment of neurodegenerative diseases. J Food Biochem. https:\/\/doi.org\/10.1111\/jfbc.14068","journal-title":"J Food Biochem"},{"key":"11198_CR117","doi-asserted-by":"publisher","first-page":"60","DOI":"10.32607\/actanaturae.10925","volume":"12","author":"ME Neganova","year":"2020","unstructured":"Neganova ME, Aleksandrova YR, Nebogatikov VO et al (2020) Promising molecular targets for pharmacological therapy of neurodegenerative pathologies. Acta Naturae 12:60\u201380. https:\/\/doi.org\/10.32607\/actanaturae.10925","journal-title":"Acta Naturae"},{"key":"11198_CR118","doi-asserted-by":"publisher","first-page":"20970","DOI":"10.1038\/s41598-020-77847-9","volume":"10","author":"A MacNamara","year":"2020","unstructured":"MacNamara A, Nakic N, Amin Al Olama A et al (2020) Network and pathway expansion of genetic disease associations identifies successful drug targets. Sci Rep 10:20970. https:\/\/doi.org\/10.1038\/s41598-020-77847-9","journal-title":"Sci Rep"},{"key":"11198_CR119","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1038\/s41380-021-01251-6","volume":"26","author":"Y-N Ou","year":"2021","unstructured":"Ou Y-N, Yang Y-X, Deng Y-T et al (2021) Identification of novel drug targets for Alzheimer\u2019s disease by integrating genetics and proteomes from brain and blood. Mol Psychiatry 26:6065\u20136073. https:\/\/doi.org\/10.1038\/s41380-021-01251-6","journal-title":"Mol Psychiatry"},{"key":"11198_CR120","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12031-021-01893-9","volume":"72","author":"H Ceylan","year":"2022","unstructured":"Ceylan H (2022) Integrated bioinformatics analysis to identify alternative therapeutic targets for Alzheimer\u2019s disease: insights from a synaptic machinery perspective. J Mol Neurosci 72:273\u2013286. https:\/\/doi.org\/10.1007\/s12031-021-01893-9","journal-title":"J Mol Neurosci"},{"key":"11198_CR121","doi-asserted-by":"publisher","first-page":"23829","DOI":"10.1007\/s00521-021-05974-z","volume":"35","author":"P Arora","year":"2023","unstructured":"Arora P, Mishra A, Malhi A (2023) N-semble-based method for identifying Parkinson\u2019s disease genes. Neural Comput Appl 35:23829\u201323839. https:\/\/doi.org\/10.1007\/s00521-021-05974-z","journal-title":"Neural Comput Appl"},{"key":"11198_CR122","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1080\/07391102.2022.2090441","volume":"41","author":"R Sai Swaroop","year":"2023","unstructured":"Sai Swaroop R, Akhil PS, Sai Sanwid P et al (2023) Integrated multi-omic data analysis and validation with yeast model show oxidative phosphorylation modulates protein aggregation in amyotrophic lateral sclerosis. J Biomol Struct Dyn 41:5548\u20135567. https:\/\/doi.org\/10.1080\/07391102.2022.2090441","journal-title":"J Biomol Struct Dyn"},{"key":"11198_CR123","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1038\/s41467-021-27387-1","volume":"12","author":"G Png","year":"2021","unstructured":"Png G, Barysenka A, Repetto L et al (2021) Mapping the serum proteome to neurological diseases using whole genome sequencing. Nat Commun 12:7042. https:\/\/doi.org\/10.1038\/s41467-021-27387-1","journal-title":"Nat Commun"},{"key":"11198_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009224","volume":"17","author":"DA Baird","year":"2021","unstructured":"Baird DA, Liu JZ, Zheng J et al (2021) Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome. PLoS Genet 17:e1009224. https:\/\/doi.org\/10.1371\/journal.pgen.1009224","journal-title":"PLoS Genet"},{"key":"11198_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.639160","author":"SAP Dharshini","year":"2021","unstructured":"Dharshini SAP, Jemimah S, Taguchi YH, Gromiha MM (2021) Exploring common therapeutic targets for neurodegenerative disorders using transcriptome study. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2021.639160","journal-title":"Front Genet"},{"key":"11198_CR126","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O (2021) Biomarkers for neurodegenerative diseases. Nat Med 27:954\u2013963. https:\/\/doi.org\/10.1038\/s41591-021-01382-x","journal-title":"Nat Med"},{"key":"11198_CR127","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.3390\/ijms22094820","volume":"22","author":"V La Cognata","year":"2021","unstructured":"La Cognata V, Morello G, Cavallaro S (2021) Omics data and their integrative analysis to support stratified medicine in neurodegenerative diseases. Int J Mol Sci 22:4820. https:\/\/doi.org\/10.3390\/ijms22094820","journal-title":"Int J Mol Sci"},{"key":"11198_CR128","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab121","author":"L Xie","year":"2021","unstructured":"Xie L, He B, Varathan P et al (2021) Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer\u2019s disease. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab121","journal-title":"Brief Bioinform"},{"key":"11198_CR129","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3390\/futurepharmacol3040045","volume":"3","author":"GN Dimitrakopoulos","year":"2023","unstructured":"Dimitrakopoulos GN, Vrahatis AG, Exarchos TP et al (2023) Drug and protein interaction network construction for drug repurposing in Alzheimer\u2019s disease. Future Pharmacol 3:731\u2013741. https:\/\/doi.org\/10.3390\/futurepharmacol3040045","journal-title":"Future Pharmacol"},{"key":"11198_CR130","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1021\/acs.jcim.3c00018","volume":"63","author":"M Zhou","year":"2023","unstructured":"Zhou M, Sun J, Yu Z et al (2023) Investigation of anti-Alzheimer\u2019s mechanisms of Sarsasapogenin derivatives by network-based combining structure-based methods. J Chem Inf Model 63:2881\u20132894. https:\/\/doi.org\/10.1021\/acs.jcim.3c00018","journal-title":"J Chem Inf Model"},{"key":"11198_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26642","volume":"10","author":"S He","year":"2024","unstructured":"He S, Shi J, Chai H et al (2024) Mechanisms with network pharmacology approach of Ginsenosides in Alzheimer\u2019s disease. Heliyon 10:e26642. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26642","journal-title":"Heliyon"},{"key":"11198_CR132","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14558","author":"J Chen","year":"2024","unstructured":"Chen J, Rao J, Lu H et al (2024) Network pharmacology and experimental verification to explore the effect of Hedyotis diffusa on Alzheimer\u2019s disease. Chem Biol Drug Des. https:\/\/doi.org\/10.1111\/cbdd.14558","journal-title":"Chem Biol Drug Des"},{"key":"11198_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28852","volume":"10","author":"N Patil","year":"2024","unstructured":"Patil N, Dhariwal R, Mohammed A et al (2024) Network pharmacology-based approach to elucidate the pharmacologic mechanisms of natural compounds from Dictyostelium discoideum for Alzheimer\u2019s disease treatment. Heliyon 10:e28852. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28852","journal-title":"Heliyon"},{"key":"11198_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117291","volume":"319","author":"J Zhi","year":"2024","unstructured":"Zhi J, Yin L, Zhang Z et al (2024) Network pharmacology-based analysis of Jin-Si-Wei on the treatment of Alzheimer\u2019s disease. J Ethnopharmacol 319:117291. https:\/\/doi.org\/10.1016\/j.jep.2023.117291","journal-title":"J Ethnopharmacol"},{"key":"11198_CR135","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2147\/DDDT.S450739","volume":"18","author":"Y Peng","year":"2024","unstructured":"Peng Y, Zhou C (2024) Network pharmacology and molecular docking identify the potential mechanism and therapeutic role of Scutellaria baicalensis in Alzheimer\u2019s disease. Drug Des Devel Ther 18:1199\u20131219. https:\/\/doi.org\/10.2147\/DDDT.S450739","journal-title":"Drug Des Devel Ther"},{"key":"11198_CR136","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12906-024-04527-w","volume":"24","author":"Y Hu","year":"2024","unstructured":"Hu Y, Hao R, Li D et al (2024) Experimental verification about treatment of Bu-Shen-Yi-Jing-Fang in Alzheimer\u2019s disease by the analysis of the feasible signaling pathway of network pharmacology. BMC Complement Med Ther 24:222. https:\/\/doi.org\/10.1186\/s12906-024-04527-w","journal-title":"BMC Complement Med Ther"},{"key":"11198_CR137","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41065-023-00301-z","volume":"161","author":"T Chen","year":"2024","unstructured":"Chen T, Lei Y, Li M et al (2024) Network pharmacology to unveil the mechanism of suanzaoren decoction in the treatment of Alzheimer\u2019s with diabetes. Hereditas 161:2. https:\/\/doi.org\/10.1186\/s41065-023-00301-z","journal-title":"Hereditas"},{"key":"11198_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117976","volume":"328","author":"S Cheung","year":"2024","unstructured":"Cheung S, Zhong Y, Wu L et al (2024) Mechanism interpretation of Guhan Yangshengjing for protection against Alzheimer\u2019s disease by network pharmacology and molecular docking. J Ethnopharmacol 328:117976. https:\/\/doi.org\/10.1016\/j.jep.2024.117976","journal-title":"J Ethnopharmacol"},{"key":"11198_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5921","author":"S Shi","year":"2024","unstructured":"Shi S, Hu T (2024) Network pharmacology study on fermented soybeans for the prevention of Alzheimer\u2019s disease in older individuals. Biomed Chromatogr. https:\/\/doi.org\/10.1002\/bmc.5921","journal-title":"Biomed Chromatogr"},{"key":"11198_CR140","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3892\/br.2023.1620","volume":"18","author":"X Shi","year":"2023","unstructured":"Shi X, Luo Y, Yang L, Duan X (2023) Protective effect of Gastrodia elata Blume in a Caenorhabditis elegans model of Alzheimer\u2019s disease based on network pharmacology. Biomed Rep 18:37. https:\/\/doi.org\/10.3892\/br.2023.1620","journal-title":"Biomed Rep"},{"key":"11198_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1059496","author":"W Wei","year":"2023","unstructured":"Wei W, Yao J, Zhang T et al (2023) Network pharmacology reveals that Berberine may function against Alzheimer\u2019s disease via the AKT signaling pathway. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2023.1059496","journal-title":"Front Neurosci"},{"key":"11198_CR142","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.18632\/aging.204536","volume":"15","author":"H Pei","year":"2023","unstructured":"Pei H, He L, Shi M et al (2023) PI3K-Akt signaling pathway based on network pharmacology for the anti-Alzheimer\u2019s disease effect of licorice stem flavonoids. Aging 15:3381\u20133393. https:\/\/doi.org\/10.18632\/aging.204536","journal-title":"Aging"},{"key":"11198_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2022.943400","volume":"16","author":"W Xu","year":"2022","unstructured":"Xu W, Ren B, Zhang Z et al (2022) Network pharmacology analysis reveals neuroprotective effects of the Qin-Zhi-Zhu-Dan Formula in Alzheimer\u2019s disease. Front Neurosci 16:1. https:\/\/doi.org\/10.3389\/fnins.2022.943400","journal-title":"Front Neurosci"},{"key":"11198_CR144","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13040-020-00212-z","volume":"13","author":"J You","year":"2020","unstructured":"You J, Li C, Chen W et al (2020) A network pharmacology-based study on Alzheimer disease prevention and treatment of Qiong Yu Gao. BioData Min 13:2. https:\/\/doi.org\/10.1186\/s13040-020-00212-z","journal-title":"BioData Min"},{"key":"11198_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8706589","volume":"2019","author":"Q Zeng","year":"2019","unstructured":"Zeng Q, Li L, Jin Y et al (2019) A network pharmacology approach to reveal the underlying mechanisms of Paeonia lactiflora Pall. On the treatment of Alzheimer\u2019s disease. Evid-Based Complement Altern Med 2019:1\u201312. https:\/\/doi.org\/10.1155\/2019\/8706589","journal-title":"Evid-Based Complement Altern Med"},{"key":"11198_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26916","volume":"10","author":"X Gao","year":"2024","unstructured":"Gao X, Fu J, Yu D et al (2024) Integrated network pharmacology and phosphoproteomic analyses of Baichanting in Parkinson\u2019s disease model mice. Heliyon 10:e26916. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26916","journal-title":"Heliyon"},{"key":"11198_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108195","volume":"172","author":"DSN Sasikumar","year":"2024","unstructured":"Sasikumar DSN, Thiruselvam P, Sundararajan V et al (2024) Insights into dietary phytochemicals targeting Parkinson\u2019s disease key genes and pathways: a network pharmacology approach. Comput Biol Med 172:108195. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108195","journal-title":"Comput Biol Med"},{"key":"11198_CR148","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12906-023-03999-6","volume":"23","author":"Y Wu","year":"2023","unstructured":"Wu Y, Bai Y, Lu Y et al (2023) Transcriptome sequencing and network pharmacology-based approach to reveal the effect and mechanism of Ji Chuan Jian against Parkinson\u2019s disease. BMC Complement Med Ther 23:182. https:\/\/doi.org\/10.1186\/s12906-023-03999-6","journal-title":"BMC Complement Med Ther"},{"key":"11198_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.836500","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zhao J, Yang S et al (2022) Network pharmacology and absolute bacterial quantification-combined approach to explore the mechanism of Tianqi Pingchan granule against 6-OHDA-induced Parkinson\u2019s disease in rats. Front Nutr. https:\/\/doi.org\/10.3389\/fnut.2022.836500","journal-title":"Front Nutr"},{"key":"11198_CR150","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.3390\/biomedicines11102756","volume":"11","author":"Y Lakshmi","year":"2023","unstructured":"Lakshmi Y, Prasanth D, Kumar K et al (2023) Unravelling the molecular mechanisms of a quercetin nanocrystal for treating potential Parkinson\u2019s disease in a rotenone model: supporting evidence of network pharmacology and in silico data analysis. Biomedicines 11:2756. https:\/\/doi.org\/10.3390\/biomedicines11102756","journal-title":"Biomedicines"},{"key":"11198_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1007556","author":"Y-C Yan","year":"2022","unstructured":"Yan Y-C, Xu Z-H, Wang J, Yu W-B (2022) Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson\u2019s disease. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1007556","journal-title":"Front Pharmacol"},{"key":"11198_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.581984","author":"W Du","year":"2020","unstructured":"Du W, Liang X, Wang S et al (2020) The underlying mechanism of Paeonia lactiflora Pall. in Parkinson\u2019s disease based on a network pharmacology approach. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.581984","journal-title":"Front Pharmacol"},{"key":"11198_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117850","volume":"326","author":"X Jin","year":"2024","unstructured":"Jin X, Dong W, Chang K, Yan Y (2024) Research on the signaling pathways related to the intervention of traditional Chinese medicine in Parkinson\u2019s disease: a literature review. J Ethnopharmacol 326:117850. https:\/\/doi.org\/10.1016\/j.jep.2024.117850","journal-title":"J Ethnopharmacol"},{"key":"11198_CR154","doi-asserted-by":"publisher","first-page":"13154","DOI":"10.1038\/s41598-021-92701-2","volume":"11","author":"P Quan","year":"2021","unstructured":"Quan P, Wang K, Yan S et al (2021) Integrated network analysis identifying potential novel drug candidates and targets for Parkinson\u2019s disease. Sci Rep 11:13154. https:\/\/doi.org\/10.1038\/s41598-021-92701-2","journal-title":"Sci Rep"},{"key":"11198_CR155","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.3390\/molecules27154780","volume":"27","author":"J Liu","year":"2022","unstructured":"Liu J, Peng D, Li J et al (2022) Identification of potential Parkinson\u2019s disease drugs based on multi-source data fusion and convolutional neural network. Molecules 27:4780. https:\/\/doi.org\/10.3390\/molecules27154780","journal-title":"Molecules"},{"key":"11198_CR156","doi-asserted-by":"publisher","first-page":"117009","DOI":"10.1016\/j.jep.2023.117009","volume":"318","author":"J Wang","year":"2024","unstructured":"Wang J, Liu Q-T, Shen D-Y et al (2024) Network pharmacology analysis of the active ingredients of Corydalis hendersonii Hemsl. and their effects on eliminating neuroinflammation and improving motor functions in MPTP-intoxicated mice. J Ethnopharmacol 318:117009. https:\/\/doi.org\/10.1016\/j.jep.2023.117009","journal-title":"J Ethnopharmacol"},{"key":"11198_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34113","volume":"10","author":"A Sun","year":"2024","unstructured":"Sun A, Li Y, Miao Y et al (2024) Research on the mechanism of ursolic acid for treating Parkinson\u2019s disease by network pharmacology and experimental verification. Heliyon 10:e34113. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34113","journal-title":"Heliyon"},{"key":"11198_CR158","doi-asserted-by":"publisher","first-page":"9","DOI":"10.33483\/jfpau.1340094","volume":"48","author":"S Priya","year":"2023","unstructured":"Priya S, Tyagi M, Dhandayuthapani D, Saravanan J (2023) Unveiling the therapeutic potential of ginkgo biloba: a network pharmacology approach for Parkinson\u2019s disease. Ankara Universitesi Eczacilik Fakultesi Dergisi 48:9. https:\/\/doi.org\/10.33483\/jfpau.1340094","journal-title":"Ankara Universitesi Eczacilik Fakultesi Dergisi"},{"issue":"1","key":"11198_CR159","first-page":"596","volume":"15","author":"P Ni","year":"2023","unstructured":"Ni P, Zhao B, Pang Y, Pan K (2023) Mechanism of Tianma Gouteng decoction in the treatment of Parkinson\u2019s disease based on network pharmacology and molecular docking. Am J Transl Res 15(1):596","journal-title":"Am J Transl Res"},{"key":"11198_CR160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/4758189","volume":"2022","author":"Z Shen","year":"2022","unstructured":"Shen Z, Yu M, Zhang S (2022) Network pharmacology and molecular docking analyses unveil the mechanisms of Yiguanjian decoction against Parkinson\u2019s disease from inner\/outer brain perspective. Biomed Res Int 2022:1\u201325. https:\/\/doi.org\/10.1155\/2022\/4758189","journal-title":"Biomed Res Int"},{"key":"11198_CR161","doi-asserted-by":"publisher","DOI":"10.1177\/1934578X221102029","author":"W Zhang","year":"2022","unstructured":"Zhang W, Chen J, Liu H (2022) Network pharmacology and molecular docking-based prediction of the molecular targets and signaling pathways of ginseng in the treatment of Parkinson\u2019s disease. Nat Prod Commun. https:\/\/doi.org\/10.1177\/1934578X221102029","journal-title":"Nat Prod Commun"},{"key":"11198_CR162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.54691\/fsd.v2i6.952","volume":"2","author":"F Xie","year":"2022","unstructured":"Xie F (2022) Network pharmacology and molecular docking analysis on mechanisms of isobavachalcone in Parkinson\u2019s disease. Front Sustain Dev 2:1\u20139. https:\/\/doi.org\/10.54691\/fsd.v2i6.952","journal-title":"Front Sustain Dev"},{"key":"11198_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/4490081","volume":"2021","author":"D Lin","year":"2021","unstructured":"Lin D, Zeng Y, Tang D, Cai Y (2021) Study on the mechanism of Liuwei Dihuang pills in treating Parkinson\u2019s disease based on network pharmacology. Biomed Res Int 2021:1\u201312. https:\/\/doi.org\/10.1155\/2021\/4490081","journal-title":"Biomed Res Int"},{"key":"11198_CR164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/1752570","volume":"2021","author":"Y Liu","year":"2021","unstructured":"Liu Y, Yu L, Zhang J et al (2021) Network pharmacology-based and molecular docking-based analysis of Suanzaoren decoction for the treatment of Parkinson\u2019s disease with sleep disorder. Biomed Res Int 2021:1\u201312. https:\/\/doi.org\/10.1155\/2021\/1752570","journal-title":"Biomed Res Int"},{"key":"11198_CR165","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1517\/13543784.2012.657303","volume":"21","author":"JA Morren","year":"2012","unstructured":"Morren JA, Galvez-Jimenez N (2012) Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis. Expert Opin Investig Drugs 21:297\u2013320. https:\/\/doi.org\/10.1517\/13543784.2012.657303","journal-title":"Expert Opin Investig Drugs"},{"key":"11198_CR166","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/antiox10071012","volume":"10","author":"X Yang","year":"2021","unstructured":"Yang X, Ji Y, Wang W et al (2021) Amyotrophic lateral sclerosis: molecular mechanisms, biomarkers, and therapeutic strategies. Antioxidants 10:1012. https:\/\/doi.org\/10.3390\/antiox10071012","journal-title":"Antioxidants"},{"key":"11198_CR167","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.2174\/1570159X21666230824091601","volume":"22","author":"B Dey","year":"2024","unstructured":"Dey B, Kumar A, Patel AB (2024) Pathomechanistic networks of motor system injury in amyotrophic lateral sclerosis. Curr Neuropharmacol 22:1778\u20131806. https:\/\/doi.org\/10.2174\/1570159X21666230824091601","journal-title":"Curr Neuropharmacol"},{"key":"11198_CR168","doi-asserted-by":"publisher","first-page":"96","DOI":"10.14336\/AD.2023.0519","volume":"15","author":"D He","year":"2024","unstructured":"He D, Xu Y, Liu M, Cui L (2024) The inflammatory puzzle: piecing together the links between neuroinflammation and amyotrophic lateral sclerosis. Aging Dis 15:96. https:\/\/doi.org\/10.14336\/AD.2023.0519","journal-title":"Aging Dis"},{"key":"11198_CR169","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.3390\/ijms22126352","volume":"22","author":"E Obrador","year":"2021","unstructured":"Obrador E, Salvador-Palmer R, L\u00f3pez-Blanch R et al (2021) The link between oxidative stress, redox status, bioenergetics and mitochondria in the pathophysiology of ALS. Int J Mol Sci 22:6352. https:\/\/doi.org\/10.3390\/ijms22126352","journal-title":"Int J Mol Sci"},{"key":"11198_CR170","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac442","author":"T Das","year":"2022","unstructured":"Das T, Kaur H, Gour P et al (2022) Intersection of network medicine and machine learning towards investigating the key biomarkers and pathways underlying amyotrophic lateral sclerosis: a systematic review. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbac442","journal-title":"Brief Bioinform"},{"key":"11198_CR171","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1038\/s41598-021-85061-4","volume":"11","author":"JC Wang","year":"2021","unstructured":"Wang JC, Ramaswami G, Geschwind DH (2021) Gene co-expression network analysis in human spinal cord highlights mechanisms underlying amyotrophic lateral sclerosis susceptibility. Sci Rep 11:5748. https:\/\/doi.org\/10.1038\/s41598-021-85061-4","journal-title":"Sci Rep"},{"key":"11198_CR172","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268159","volume":"17","author":"KH Jensen","year":"2022","unstructured":"Jensen KH, Stalder AK, Wernersson R et al (2022) A molecular view of amyotrophic lateral sclerosis through the lens of interaction network modules. PLoS ONE 17:e0268159. https:\/\/doi.org\/10.1371\/journal.pone.0268159","journal-title":"PLoS ONE"},{"key":"11198_CR173","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.0440","author":"J Xin","year":"2024","unstructured":"Xin J, Huang S, Wen J et al (2024) Drug screening and validation targeting TDP-43 proteinopathy for amyotrophic lateral sclerosis. Aging Dis. https:\/\/doi.org\/10.14336\/AD.2024.0440","journal-title":"Aging Dis"},{"key":"11198_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00098","author":"R Malik","year":"2020","unstructured":"Malik R, Wiedau M (2020) Therapeutic approaches targeting protein aggregation in amyotrophic lateral sclerosis. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2020.00098","journal-title":"Front Mol Neurosci"},{"key":"11198_CR175","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/21678421.2023.2278503","volume":"25","author":"A Genge","year":"2024","unstructured":"Genge A, Wainwright S, Vande Velde C (2024) Amyotrophic lateral sclerosis: exploring pathophysiology in the context of treatment. Amyotroph Lateral Scler Frontotemporal Degener 25:225\u2013236. https:\/\/doi.org\/10.1080\/21678421.2023.2278503","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"11198_CR176","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.3390\/ijms22168363","volume":"22","author":"A Kim","year":"2021","unstructured":"Kim A, Lalonde K, Truesdell A et al (2021) New avenues for the treatment of Huntington\u2019s disease. Int J Mol Sci 22:8363. https:\/\/doi.org\/10.3390\/ijms22168363","journal-title":"Int J Mol Sci"},{"key":"11198_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.611735","author":"M Czeredys","year":"2020","unstructured":"Czeredys M (2020) Dysregulation of neuronal calcium signaling via store-operated channels in Huntington\u2019s disease. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2020.611735","journal-title":"Front Cell Dev Biol"},{"key":"11198_CR178","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253037","volume":"16","author":"M Seefelder","year":"2021","unstructured":"Seefelder M, Kochanek S (2021) A meta-analysis of transcriptomic profiles of Huntington\u2019s disease patients. PLoS ONE 16:e0253037. https:\/\/doi.org\/10.1371\/journal.pone.0253037","journal-title":"PLoS ONE"},{"key":"11198_CR179","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64564","author":"TS Onur","year":"2021","unstructured":"Onur TS, Laitman A, Zhao H et al (2021) Downregulation of glial genes involved in synaptic function mitigates Huntington\u2019s disease pathogenesis. Elife. https:\/\/doi.org\/10.7554\/eLife.64564","journal-title":"Elife"},{"key":"11198_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2021.556215","volume":"14","author":"Y Bai","year":"2021","unstructured":"Bai Y, Su X, Piao L et al (2021) Involvement of astrocytes and microRNA dysregulation in neurodegenerative diseases: from pathogenesis to therapeutic potential. Front Mol Neurosci 14:1. https:\/\/doi.org\/10.3389\/fnmol.2021.556215","journal-title":"Front Mol Neurosci"},{"key":"11198_CR181","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.57017","author":"S Fern\u00e1ndez-Garc\u00eda","year":"2020","unstructured":"Fern\u00e1ndez-Garc\u00eda S, Conde-Berriozabal S, Garc\u00eda-Garc\u00eda E et al (2020) M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington\u2019s disease. Elife. https:\/\/doi.org\/10.7554\/eLife.57017","journal-title":"Elife"},{"key":"11198_CR182","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1021\/acschemneuro.0c00824","volume":"12","author":"PT Lum","year":"2021","unstructured":"Lum PT, Sekar M, Gan SH et al (2021) Protective effect of natural products against Huntington\u2019s disease: an overview of scientific evidence and understanding their mechanism of action. ACS Chem Neurosci 12:391\u2013418. https:\/\/doi.org\/10.1021\/acschemneuro.0c00824","journal-title":"ACS Chem Neurosci"},{"key":"11198_CR183","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s11064-021-03271-8","volume":"46","author":"A Fotoohi","year":"2021","unstructured":"Fotoohi A, Moloudi MR, Hosseini S et al (2021) A Novel pharmacological protective role for safranal in an animal model of Huntington\u2019s disease. Neurochem Res 46:1372\u20131379. https:\/\/doi.org\/10.1007\/s11064-021-03271-8","journal-title":"Neurochem Res"},{"key":"11198_CR184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007648","volume":"16","author":"A Ponzi","year":"2020","unstructured":"Ponzi A, Barton SJ, Bunner KD et al (2020) Striatal network modeling in Huntington\u2019s disease. PLoS Comput Biol 16:e1007648. https:\/\/doi.org\/10.1371\/journal.pcbi.1007648","journal-title":"PLoS Comput Biol"},{"key":"11198_CR185","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1093\/brain\/awab190","volume":"144","author":"H Liu","year":"2021","unstructured":"Liu H, Zhang C, Xu J et al (2021) Huntingtin silencing delays onset and slows progression of Huntington\u2019s disease: a biomarker study. Brain 144:3101\u20133113. https:\/\/doi.org\/10.1093\/brain\/awab190","journal-title":"Brain"},{"key":"11198_CR186","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/B0-12-226870-9\/00948-5","volume-title":"Encyclopedia of the neurological sciences","author":"BS Russman","year":"2003","unstructured":"Russman BS (2003) Spinal muscular atrophy. Encyclopedia of the neurological sciences. Elsevier, Amsterdam, pp 368\u2013372"},{"key":"11198_CR187","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.3390\/ijms22115913","volume":"22","author":"M-O Deguise","year":"2021","unstructured":"Deguise M-O, Chehade L, Kothary R (2021) Metabolic dysfunction in spinal muscular atrophy. Int J Mol Sci 22:5913. https:\/\/doi.org\/10.3390\/ijms22115913","journal-title":"Int J Mol Sci"},{"key":"11198_CR188","doi-asserted-by":"publisher","DOI":"10.52965\/001c.24934","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Nguyen LH, Odisho AS et al (2021) The antisense oligonucleotide Nusinersen for treatment of spinal muscular atrophy. Orthop Rev (Pavia). https:\/\/doi.org\/10.52965\/001c.24934","journal-title":"Orthop Rev (Pavia)"},{"key":"11198_CR189","doi-asserted-by":"publisher","first-page":"8962","DOI":"10.3390\/ijms22168962","volume":"22","author":"LC Chong","year":"2021","unstructured":"Chong LC, Gandhi G, Lee JM et al (2021) Drug discovery of spinal muscular atrophy (SMA) from the computational perspective: a comprehensive review. Int J Mol Sci 22:8962. https:\/\/doi.org\/10.3390\/ijms22168962","journal-title":"Int J Mol Sci"},{"key":"11198_CR190","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/brainsci11020194","volume":"11","author":"KS Ojala","year":"2021","unstructured":"Ojala KS, Reedich EJ, DiDonato CJ, Meriney SD (2021) In search of a cure: the development of therapeutics to alter the progression of spinal muscular atrophy. Brain Sci 11:194. https:\/\/doi.org\/10.3390\/brainsci11020194","journal-title":"Brain Sci"},{"key":"11198_CR191","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/mus.27358","volume":"64","author":"MS Cartwright","year":"2021","unstructured":"Cartwright MS, Upadhya S (2021) Selecting disease-modifying medications in 5q spinal muscular atrophy. Muscle Nerve 64:404\u2013412. https:\/\/doi.org\/10.1002\/mus.27358","journal-title":"Muscle Nerve"},{"key":"11198_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-med-070119-115459","volume":"72","author":"B Ravi","year":"2021","unstructured":"Ravi B, Chan-Cort\u00e9s MH, Sumner CJ (2021) Gene-targeting therapeutics for neurological disease: lessons learned from spinal muscular atrophy. Annu Rev Med 72:1\u201314. https:\/\/doi.org\/10.1146\/annurev-med-070119-115459","journal-title":"Annu Rev Med"},{"key":"11198_CR193","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1007\/s00018-021-03819-5","volume":"78","author":"R James","year":"2021","unstructured":"James R, Chaytow H, Ledahawsky LM, Gillingwater TH (2021) Revisiting the role of mitochondria in spinal muscular atrophy. Cell Mol Life Sci 78:4785\u20134804. https:\/\/doi.org\/10.1007\/s00018-021-03819-5","journal-title":"Cell Mol Life Sci"},{"key":"11198_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100346","volume":"2","author":"H Chaytow","year":"2021","unstructured":"Chaytow H, Faller KME, Huang Y-T, Gillingwater TH (2021) Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine. Cell Rep Med 2:100346. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100346","journal-title":"Cell Rep Med"},{"key":"11198_CR195","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/hmg\/ddae076","volume":"33","author":"I Tapken","year":"2024","unstructured":"Tapken I, Kuhn D, Hoffmann N et al (2024) From data to discovery: AI-guided analysis of disease-relevant molecules in spinal muscular atrophy (SMA). Hum Mol Genet 33:1367\u20131377. https:\/\/doi.org\/10.1093\/hmg\/ddae076","journal-title":"Hum Mol Genet"},{"key":"11198_CR196","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.2174\/0113816128288504240321041408","volume":"30","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, He J, Xiang L et al (2024) Molecular mechanisms of medicinal plant Securinega suffruticosa-derived compound securinine against spinal muscular atrophy based on network pharmacology and experimental verification. Curr Pharm Des 30:1178\u20131193. https:\/\/doi.org\/10.2174\/0113816128288504240321041408","journal-title":"Curr Pharm Des"},{"key":"11198_CR197","doi-asserted-by":"publisher","first-page":"10878","DOI":"10.3390\/ijms231810878","volume":"23","author":"E Zilio","year":"2022","unstructured":"Zilio E, Piano V, Wirth B (2022) Mitochondrial dysfunction in spinal muscular atrophy. Int J Mol Sci 23:10878. https:\/\/doi.org\/10.3390\/ijms231810878","journal-title":"Int J Mol Sci"},{"key":"11198_CR198","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41419-023-05573-x","volume":"14","author":"F Chemello","year":"2023","unstructured":"Chemello F, Pozzobon M, Tsansizi LI et al (2023) Dysfunctional mitochondria accumulate in a skeletal muscle knockout model of Smn1, the causal gene of spinal muscular atrophy. Cell Death Dis 14:162. https:\/\/doi.org\/10.1038\/s41419-023-05573-x","journal-title":"Cell Death Dis"},{"key":"11198_CR199","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149446","author":"KE Meijboom","year":"2021","unstructured":"Meijboom KE, Volpato V, Monz\u00f3n-Sandoval J et al (2021) Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.149446","journal-title":"JCI Insight"},{"key":"11198_CR200","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3390\/biomedicines11051254","volume":"11","author":"M Meneri","year":"2023","unstructured":"Meneri M, Abati E, Gagliardi D et al (2023) Identification of novel biomarkers of spinal muscular atrophy and therapeutic response by proteomic and metabolomic profiling of human biological fluid samples. Biomedicines 11:1254. https:\/\/doi.org\/10.3390\/biomedicines11051254","journal-title":"Biomedicines"},{"key":"11198_CR201","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1002\/bit.28780","volume":"121","author":"X Peng","year":"2024","unstructured":"Peng X, Chi Y, Wang J et al (2024) Improvement of TaC9-ABE mediated correction of human SMN2 gene. Biotechnol Bioeng 121:3059\u20133067. https:\/\/doi.org\/10.1002\/bit.28780","journal-title":"Biotechnol Bioeng"},{"key":"11198_CR202","doi-asserted-by":"publisher","first-page":"156","DOI":"10.14715\/cmb\/2023.69.13.24","volume":"69","author":"S Luo","year":"2023","unstructured":"Luo S, Yang L, Ma B et al (2023) Explore the pharmacological basis of ShengJiYiSui decoction in the treatment of amyotrophic lateral sclerosis based on network pharmacology and molecular docking technology. Cell Mol Biol 69:156\u2013161. https:\/\/doi.org\/10.14715\/cmb\/2023.69.13.24","journal-title":"Cell Mol Biol"},{"key":"11198_CR203","doi-asserted-by":"publisher","first-page":"E35101","DOI":"10.1097\/MD.0000000000035101","volume":"102","author":"X Tang","year":"2023","unstructured":"Tang X, Zhan Y, Yang B et al (2023) Exploring the mechanism of Semen Strychni in treating amyotrophic lateral sclerosis based on network pharmacology. Medicine (United States) 102:E35101. https:\/\/doi.org\/10.1097\/MD.0000000000035101","journal-title":"Medicine (United States)"},{"key":"11198_CR204","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5414\/CP204501","volume":"62","author":"J Lin","year":"2024","unstructured":"Lin J, Wang J, Wang C et al (2024) Network pharmacology analysis and clinical efficacy of the traditional Chinese medicine Bu-Shen-Jian-Pi. Part 1: biogenic components and identification of targets and signaling pathways in amyotrophic lateral sclerosis patients. Int J Clin Pharmacol Therap 62:155\u2013161. https:\/\/doi.org\/10.5414\/CP204501","journal-title":"Int J Clin Pharmacol Therap"},{"key":"11198_CR205","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6020197","author":"W Dai","year":"2018","unstructured":"Dai W, Chen H-Y, Chen CY-C (2018) A network pharmacology-based approach to investigate the novel TCM formula against Huntington\u2019s disease and validated by support vector machine model. Evid-Based Complement Altern Med. https:\/\/doi.org\/10.1155\/2018\/6020197","journal-title":"Evid-Based Complement Altern Med"},{"key":"11198_CR206","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18588","author":"MR Hossain","year":"2024","unstructured":"Hossain MR, Tareq MdMI, Biswas P et al (2024) Identification of molecular targets and small drug candidates for Huntington\u2019s disease via bioinformatics and a network-based screening approach. J Cell Mol Med. https:\/\/doi.org\/10.1111\/jcmm.18588","journal-title":"J Cell Mol Med"},{"key":"11198_CR207","doi-asserted-by":"publisher","first-page":"24","DOI":"10.26689\/cnr.v2i1.6512","volume":"2","author":"J Zhang","year":"2024","unstructured":"Zhang J, Yu Q, Zhao T, Ding X (2024) Application of network pharmacology to explore the anti-aging molecular mechanism of radix notoginseng. Clin Neurosci Res 2:24\u201338. https:\/\/doi.org\/10.26689\/cnr.v2i1.6512","journal-title":"Clin Neurosci Res"},{"key":"11198_CR208","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8508491","author":"Y Liu","year":"2020","unstructured":"Liu Y, Liu Y, Zhang W et al (2020) Network pharmacology-based strategy to investigate the pharmacological mechanisms of Ginkgo biloba extract for aging. Evid-Based Complement Altern Med. https:\/\/doi.org\/10.1155\/2020\/8508491","journal-title":"Evid-Based Complement Altern Med"},{"key":"11198_CR209","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/geroni\/igad104.3615","volume":"7","author":"J Furber","year":"2023","unstructured":"Furber J (2023) Systems biology of human aging-network model 2023. Innov Aging 7:1126\u20131126. https:\/\/doi.org\/10.1093\/geroni\/igad104.3615","journal-title":"Innov Aging"},{"key":"11198_CR210","doi-asserted-by":"publisher","first-page":"20817","DOI":"10.1073\/pnas.1913212116","volume":"116","author":"JI Castillo-Quan","year":"2019","unstructured":"Castillo-Quan JI, Tain LS, Kinghorn KJ et al (2019) A triple drug combination targeting components of the nutrient-sensing network maximizes longevity. Proc Natl Acad Sci USA 116:20817\u201320819. https:\/\/doi.org\/10.1073\/pnas.1913212116","journal-title":"Proc Natl Acad Sci USA"},{"key":"11198_CR211","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1007\/s13311-021-01064-z","volume":"18","author":"G Fiscon","year":"2021","unstructured":"Fiscon G, Conte F, Amadio S et al (2021) Drug repurposing: a network-based approach to amyotrophic lateral sclerosis. Neurotherapeutics 18:1678\u20131691. https:\/\/doi.org\/10.1007\/s13311-021-01064-z","journal-title":"Neurotherapeutics"},{"key":"11198_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.xhgg.2025.100409","volume":"6","author":"D Tan","year":"2025","unstructured":"Tan D, Chen Y, Ilboudo Y et al (2025) Caution when using network partners for target identification in drug discovery. Hum Genet Genomics Adv 6:100409. https:\/\/doi.org\/10.1016\/j.xhgg.2025.100409","journal-title":"Hum Genet Genomics Adv"},{"key":"11198_CR213","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13020-024-01056-z","volume":"20","author":"Y Zhai","year":"2025","unstructured":"Zhai Y, Liu L, Zhang F et al (2025) Network pharmacology: a crucial approach in traditional Chinese medicine research. Chin Med 20:8. https:\/\/doi.org\/10.1186\/s13020-024-01056-z","journal-title":"Chin Med"},{"key":"11198_CR214","first-page":"2024","volume":"15","author":"P-D Zhang","year":"2024","unstructured":"Zhang P-D, Ma J, Chen T (2024) Escaping the drug-bias trap: using debiasing design to improve interpretability and generalization of drug\u2013target interaction prediction. bioRxiv 15:2024\u20132109","journal-title":"bioRxiv"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11198-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11198-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11198-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T15:56:53Z","timestamp":1771775813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11198-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":214,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11198"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11198-3","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors has any conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}